Figure 2.

Increased percentages of IL-23R+ CD8+ T cells in PBMCs from SLE patients. (a, b) The percentages of IL-23R+ CD8+ T cells in PBMCs from inactive and active SLE patients, psoriatic patients and normal subjects on Day 0 (a) and Day 3 (b) are shown. The horizontal bars show the mean values. The percentages of IL-23R+ CD8+ T cells were calculated from total CD8+ T cells after lymphocyte gating. (c, d) Representative flow cytometric profiles of IL-23R+ CD8+ T cells in PBMCs from inactive (Day 0: middle panel in (c), Day 3: middle panel in (d)) and active (Day 0: right panel in (c), Day 3: right panel in (d)) SLE patients and normal subjects (Day 0: left panel in (c), Day 3: left panel in (d)) are shown.

Puwipirom et al. Arthritis Research & Therapy 2010 12:R215   doi:10.1186/ar3194
Download authors' original image